FINRA's Examination Findings & Priorities
A Look Back & What to Expect in 2018
31 January 2018
The Financial Industry Regulatory Authority (FINRA) recently issued its Report on Examination Findings, as well as its 2018 Regulatory and Examination Priorities Letter. Combined, these two reports provide insight into several broad policy issues that FINRA believes should be key points of emphasis for member firms in 2018. What are these points and how will they affect your business?
In this in-depth webinar, Foley attorneys Dean Jeske, Allison Charney, and Joe Edmondson take a closer look at the following topics:
- A Brief Review of the FINRA360 Initiative: What’s Changed & What Does it Mean?
- Examining FINRA’s 2018 Exam Findings and the Exam Priorities Letter: What’s new? What are the biggest risks?
- Learning the Hidden Nuances That Could Prove Invaluable to Your Exam Preparation.
If you have questions or would like more information, please contact Kayla Huven at [email protected].
Recording
People
Related Insights
09 May 2024
Events
The FTC Noncompete Rule: Where Do We Go From Here?
On Tuesday, April 23, 2024, the Federal Trade Commission (FTC) voted to finalize a rule abolishing the vast majority of employee noncompetes across the United States.
24 April 2024
Article
FTC Finalizes Rule Against Employee Noncompetes
On April 23, 2024, the Federal Trade Commission voted to finalize a rule abolishing the vast majority of employee noncompetes across the United States.
24 April 2024
Health Care Law Today
FDA Continues to Take Stance That it Will Not Issue CBD Rules
The FDA recently doubled down on its January 26, 2023 position that existing regulatory pathways for foods and dietary supplements are not appropriate to manage the risks of CBD and a new regulatory pathway is needed.